About: Myasthenia gravis - current treatment standards and emerging drugs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Myasthenia gravis - current treatment standards and emerging drugs Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://www.intechopen.com/books/a-look-into-myasthenia-gravis/myasthenia-gravis-current-treatment-standards-and-emerging-drugs
Description	Myasthenia gravis is very rare disorder resulting from the autoimmune destruction of postsynaptic membrane in neuromuscular junction. In the most cases, antibodies bind to nicotinic acetylcholine receptors (nAChR), although other structures (e.g. muscle specific tyrosin kinase; MuSK) can be targeted as well. Myasthenia gravis is very rare disorder resulting from the autoimmune destruction of postsynaptic membrane in neuromuscular junction. In the most cases, antibodies bind to nicotinic acetylcholine receptors (nAChR), although other structures (e.g. muscle specific tyrosin kinase; MuSK) can be targeted as well. (en)
Title	Myasthenia gravis - current treatment standards and emerging drugs (en) Myasthenia gravis - current treatment standards and emerging drugs
skos:prefLabel	Myasthenia gravis - current treatment standards and emerging drugs (en) Myasthenia gravis - current treatment standards and emerging drugs
skos:notation	RIV/60162694:G44__/12:43874595!RIV13-MO0-G44_____
http://linked.open...avai/riv/aktivita	I P S Z
http://linked.open...avai/riv/aktivity	I, P(GP203/09/P130), S, Z(MO0FVZ0000501)
http://linked.open...vai/riv/dodaniDat	2013
http://linked.open...aciTvurceVysledku	Žďárová Karasová, Jana Musílek, Kamil Píša, Libor
http://linked.open.../riv/druhVysledku	C - Kapitola v knize
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ministerstvo obrany / Univerzita obrany - Fakulta vojenského zdravotnictví Hradec Králové
http://linked.open...dnocenehoVysledku	152604
http://linked.open...ai/riv/idVysledku	RIV/60162694:G44__/12:43874595
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	biological treatment; immunosuppressant; corticosteroid; acetylcholinesterase inhibitor; Myasthenia gravis (en)
http://linked.open.../riv/klicoveSlovo	immunosuppressant corticosteroid Myasthenia gravis biological treatment acetylcholinesterase inhibitor
http://linked.open...ontrolniKodProRIV	[EBD46A5542FD]
http://linked.open...i/riv/mistoVydani	Rijeka
http://linked.open...i/riv/nazevZdroje	A look into Myasthenia gravis
http://linked.open...in/vavai/riv/obor	FR
http://linked.open...ichTvurcuVysledku	3 (xsd:int)
http://linked.open...v/pocetStranKnihy	106 (xsd:int)
http://linked.open...cetTvurcuVysledku	6 (xsd:int)
http://linked.open...vavai/riv/projekt	Development of novel acetylcholinesterase inhibitors as treatment of Myasthenia Gravis
http://linked.open...UplatneniVysledku	2012
http://linked.open...iv/tvurceVysledku	Kuča, Kamil Musílek, Kamil Žďárová Karasová, Jana Holas, Ondřej Horová, Anna Komlóová, Markéta
http://linked.open...n/vavai/riv/zamer	Zdravotnická problematika ZHN
number of pages	20 (xsd:int)
http://bibframe.org/vocab/doi	10.5772/31127
http://purl.org/ne...btex#hasPublisher	InTech
https://schema.org/isbn	978-953-307-821-2
http://localhost/t...ganizacniJednotka	G44

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software